• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX15 HOLLOW FIBER OXYGENATOR; BLOOD GAS OXYGENATOR Back to Search Results
Catalog Number CX-XRY40801
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/26/2015
Event Type  malfunction  
Event Description
The user facility reported thrombus found in the fx15 device.Follow up communication with the user facility reported the following information: a mvp+tap operation was conducted with capiox fx15; about three (3) hours after cpb on, and just after ao declamp, it was noted that a lot of thrombus was adhered inside the reservoir; the operation was continued and completed; there was no harm to the patient.
 
Manufacturer Narrative
The actual device was returned to the manufacturing facility for evaluation.Visual inspection upon receipt did not find any visible break on it.It was found that blood which had flowed out of the reservoir formed into thrombus at the suction ports.Visual inspection, after saline solution having been let to flow into the actual sample by gravity, revealed the thrombus formation on the lower parts of the vinous filter and cr filter around the solution level of 1000 - 1500ml.Electron microscopic inspection of the thrombus formed at the suction ports revealed agglutinated blood corpuscles.Electron microscopic inspection of the thrombus formed on the lower parts of the vinous filter and cr filter revealed agglutinated blood corpuscles.To check any plugging of the venous filter and the cr-filter, the actual sample was rinsed , dried and built into a circuit with the factory-reserved tubes.Then bovine blood was circulated in the venous filter and cr filter at the flow rate of 4l/min.For three (3) hours.The level of bovine blood in the venous filter was confirmed to be the same as that in the cr-filter.This indicates that either the venous filter or the cr filter has not gotten plugged.The actual sample was rinsed again and the venous filter was taken out of the reservoir for closer visual inspection.No anomaly was confirmed in the state of the filter-net with the presence of no break on it.Electron microscopic inspection of the venous filter did not reveal any anomaly in the state of the meshes.The cr filter was taken out of the reservoir for closer visual inspection.No anomaly was confirmed in the state of the filter-net with the presence of no break on it.On the portion where the thrombus had been adhering, the filter was found to have been discolored with pigmentation.Electron microscopic inspection of the cr filter did not reveal any anomaly in the state of the meshes, with no plugging or break.A review of the device history record of the involved product code/lot# combination confirmed there was no production related problem.A search of the complaint file did not find any other report of this nature with the involved product code /lot# combination.There is no evidence that this event was related to a device defect or malfunction.Although the exact cause cannot be determined based on the available information, the appearance of the involved sample is most consistent with blood in which coagulation factors had been activated was flowed into the reservoir and stagnated on the solution level, leading to the thrombus formation.The potential for such an event is addressed in the warning / precautions section of the instructions-for-use by statements such as "adequate heparinization of the blood is required to prevent it from clotting in the system", and "do not reduce heparin during circulation.Otherwise, blood clotting might occur." all available information has been placed on file in quality management for appropriate tracking, trending and follow up.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX15 HOLLOW FIBER OXYGENATOR
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
kathleen little
950 elkton blvd.
elkton, MD 21921
8002837866
MDR Report Key4931579
MDR Text Key6013911
Report Number9681834-2015-00139
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 06/26/2015,07/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2017
Device Catalogue NumberCX-XRY40801
Device Lot Number150402
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/29/2015
Is the Reporter a Health Professional? No
Distributor Facility Aware Date06/26/2015
Device Age1 MO
Event Location Hospital
Date Report to Manufacturer06/26/2015
Date Manufacturer Received06/26/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/02/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-